Outcomes which were assessed | RR with 95% CI | P value | I2 value (%) |
---|---|---|---|
Major adverse cardiac events | 0.69 [0.54–0.88] | 0.002 | 0 |
Target lesion failure | 0.66 [0.48–0.91] | 0.01 | 0 |
All-cause mortality | 0.79 [0.51–1.22] | 0.28 | 32 |
Cardiac death | 0.75 [0.42–1.33] | 0.32 | 3 |
Myocardial infarction | 0.80 [0.53–1.20] | 0.28 | 15 |
Any revascularization | 0.80 [0.59–1.10] | 0.18 | 0 |
Target lesion revascularization | 0.67 [0.39–1.14] | 0.14 | 0 |
Target vessel revascularization | 0.74 [0.48–1.13] | 0.16 | 0 |
Total stent thrombosis | 1.13 [0.60–2.13] | 0.70 | 0 |
Definite stent thrombosis | 1.12 [0.38–3.31] | 0.84 | 0 |
Probable stent thrombosis | 0.87 [0.37–2.09] | 0.76 | 0 |
Possible stent thrombosis | 1.19 [0.50–2.87] | 0.69 | 0 |
Late stent thrombosis | 1.00 [0.17–5.72] | 1.00 | 0 |